Review



viruses aav8 cmv  (Vector Biolabs)


Bioz Verified Symbol Vector Biolabs is a verified supplier
Bioz Manufacturer Symbol Vector Biolabs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    Vector Biolabs viruses aav8 cmv
    Viruses Aav8 Cmv, supplied by Vector Biolabs, used in various techniques. Bioz Stars score: 95/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/viruses aav8 cmv/product/Vector Biolabs
    Average 95 stars, based on 3 article reviews
    viruses aav8 cmv - by Bioz Stars, 2026-03
    95/100 stars

    Images



    Similar Products

    97
    TaKaRa aav pro hek 293t cells
    Aav Pro Hek 293t Cells, supplied by TaKaRa, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/aav pro hek 293t cells/product/TaKaRa
    Average 97 stars, based on 1 article reviews
    aav pro hek 293t cells - by Bioz Stars, 2026-03
    97/100 stars
      Buy from Supplier

    93
    Repligen Corp avipure aav affinity resins
    Avipure Aav Affinity Resins, supplied by Repligen Corp, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/avipure aav affinity resins/product/Repligen Corp
    Average 93 stars, based on 1 article reviews
    avipure aav affinity resins - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    90
    Obio Technology Corp Ltd aav vectors harboring the hsyn-specific promoter and encoding shrna1 targeting brd4
    Aav Vectors Harboring The Hsyn Specific Promoter And Encoding Shrna1 Targeting Brd4, supplied by Obio Technology Corp Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/aav vectors harboring the hsyn-specific promoter and encoding shrna1 targeting brd4/product/Obio Technology Corp Ltd
    Average 90 stars, based on 1 article reviews
    aav vectors harboring the hsyn-specific promoter and encoding shrna1 targeting brd4 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    95
    Vector Biolabs viruses aav8 cmv
    Viruses Aav8 Cmv, supplied by Vector Biolabs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/viruses aav8 cmv/product/Vector Biolabs
    Average 95 stars, based on 1 article reviews
    viruses aav8 cmv - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    95
    Vector Biolabs mouse sost
    Mouse Sost, supplied by Vector Biolabs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse sost/product/Vector Biolabs
    Average 95 stars, based on 1 article reviews
    mouse sost - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    97
    TaKaRa aav pro 293t cells
    Aav Pro 293t Cells, supplied by TaKaRa, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/aav pro 293t cells/product/TaKaRa
    Average 97 stars, based on 1 article reviews
    aav pro 293t cells - by Bioz Stars, 2026-03
    97/100 stars
      Buy from Supplier

    96
    MedChemExpress aav acadl as1842856 group
    Aav Acadl As1842856 Group, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/aav acadl as1842856 group/product/MedChemExpress
    Average 96 stars, based on 1 article reviews
    aav acadl as1842856 group - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    95
    Vector Biolabs tbg promoter
    Acute RACK1 deficiency disrupts glucose homeostasis. ( A ) Western blotting analysis of multiple tissues showing liver-specific RACK1 knockout in RACK1 fl/fl mice retro-orbitally injected with <t>AAV8-TBG-GFP</t> (GFP) <t>or</t> <t>AAV8-TBG-iCre</t> (Cre). L, liver; K, kidney; SK, skeletal muscle; H, heart; B, brain. ( B ) Blood glucose levels in GFP- or Cre-injected RACK1 fl/fl mice measured under non-fasted (NF) conditions and after 6 or 18 hours of fasting. ∗ P < .05 compared with GFP controls; 2-tailed Student’s t -test. ( C–F ) Metabolic tolerance tests in GFP and Cre mice: ( C ) insulin tolerance test, ( D ) glucose tolerance test, ( E ) pyruvate tolerance test, and ( F ) glucagon tolerance test. Area under the curve (AUC) quantifications for ( D–F ) are shown below each graph. Group differences over time were analyzed by 2-way repeated-measures ANOVA (time × genotype) with Sidak’s post hoc tests for point-by-point comparisons (n = 6–8 per group). AUCs were compared using 2-tailed unpaired Student’s t -tests. ∗, ∗∗, ∗∗∗ P < .05, .01 and 001 vs GFP, respectively.
    Tbg Promoter, supplied by Vector Biolabs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/tbg promoter/product/Vector Biolabs
    Average 95 stars, based on 1 article reviews
    tbg promoter - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    95
    Vector Biolabs aav tbg icre
    Acute RACK1 deficiency disrupts glucose homeostasis. ( A ) Western blotting analysis of multiple tissues showing liver-specific RACK1 knockout in RACK1 fl/fl mice retro-orbitally injected with <t>AAV8-TBG-GFP</t> (GFP) <t>or</t> <t>AAV8-TBG-iCre</t> (Cre). L, liver; K, kidney; SK, skeletal muscle; H, heart; B, brain. ( B ) Blood glucose levels in GFP- or Cre-injected RACK1 fl/fl mice measured under non-fasted (NF) conditions and after 6 or 18 hours of fasting. ∗ P < .05 compared with GFP controls; 2-tailed Student’s t -test. ( C–F ) Metabolic tolerance tests in GFP and Cre mice: ( C ) insulin tolerance test, ( D ) glucose tolerance test, ( E ) pyruvate tolerance test, and ( F ) glucagon tolerance test. Area under the curve (AUC) quantifications for ( D–F ) are shown below each graph. Group differences over time were analyzed by 2-way repeated-measures ANOVA (time × genotype) with Sidak’s post hoc tests for point-by-point comparisons (n = 6–8 per group). AUCs were compared using 2-tailed unpaired Student’s t -tests. ∗, ∗∗, ∗∗∗ P < .05, .01 and 001 vs GFP, respectively.
    Aav Tbg Icre, supplied by Vector Biolabs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/aav tbg icre/product/Vector Biolabs
    Average 95 stars, based on 1 article reviews
    aav tbg icre - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    Image Search Results


    Acute RACK1 deficiency disrupts glucose homeostasis. ( A ) Western blotting analysis of multiple tissues showing liver-specific RACK1 knockout in RACK1 fl/fl mice retro-orbitally injected with AAV8-TBG-GFP (GFP) or AAV8-TBG-iCre (Cre). L, liver; K, kidney; SK, skeletal muscle; H, heart; B, brain. ( B ) Blood glucose levels in GFP- or Cre-injected RACK1 fl/fl mice measured under non-fasted (NF) conditions and after 6 or 18 hours of fasting. ∗ P < .05 compared with GFP controls; 2-tailed Student’s t -test. ( C–F ) Metabolic tolerance tests in GFP and Cre mice: ( C ) insulin tolerance test, ( D ) glucose tolerance test, ( E ) pyruvate tolerance test, and ( F ) glucagon tolerance test. Area under the curve (AUC) quantifications for ( D–F ) are shown below each graph. Group differences over time were analyzed by 2-way repeated-measures ANOVA (time × genotype) with Sidak’s post hoc tests for point-by-point comparisons (n = 6–8 per group). AUCs were compared using 2-tailed unpaired Student’s t -tests. ∗, ∗∗, ∗∗∗ P < .05, .01 and 001 vs GFP, respectively.

    Journal: Cellular and Molecular Gastroenterology and Hepatology

    Article Title: A Dual-compartment Scaffolding Role for Receptor for Activate C Kinase 1 in Hepatic Glucagon Signaling and Gluconeogenesis

    doi: 10.1016/j.jcmgh.2025.101666

    Figure Lengend Snippet: Acute RACK1 deficiency disrupts glucose homeostasis. ( A ) Western blotting analysis of multiple tissues showing liver-specific RACK1 knockout in RACK1 fl/fl mice retro-orbitally injected with AAV8-TBG-GFP (GFP) or AAV8-TBG-iCre (Cre). L, liver; K, kidney; SK, skeletal muscle; H, heart; B, brain. ( B ) Blood glucose levels in GFP- or Cre-injected RACK1 fl/fl mice measured under non-fasted (NF) conditions and after 6 or 18 hours of fasting. ∗ P < .05 compared with GFP controls; 2-tailed Student’s t -test. ( C–F ) Metabolic tolerance tests in GFP and Cre mice: ( C ) insulin tolerance test, ( D ) glucose tolerance test, ( E ) pyruvate tolerance test, and ( F ) glucagon tolerance test. Area under the curve (AUC) quantifications for ( D–F ) are shown below each graph. Group differences over time were analyzed by 2-way repeated-measures ANOVA (time × genotype) with Sidak’s post hoc tests for point-by-point comparisons (n = 6–8 per group). AUCs were compared using 2-tailed unpaired Student’s t -tests. ∗, ∗∗, ∗∗∗ P < .05, .01 and 001 vs GFP, respectively.

    Article Snippet: Acute deletion of RACK1 gene in the liver was achieved through the injection of AAV viruses (1 × 10 11 genome copies/mouse) encoding Cre recombinase under the TBG promoter (AAV-TBG-iCre; Vector Biolabs) into the retroorbital vein of RACK1 fl/fl transgenic mice.

    Techniques: Western Blot, Knock-Out, Injection

    RACK1 deficiency impairs hepatic gluconeogenesis in vitro. Primary hepatocytes were isolated from RACK1 fl/fl mice injected with AAV8-TBG-GFP (GFP) or iCre (Cre) and subjected to glucose production assays. ( A ) Glucose output was measured under basal conditions or following stimulation with glucagon (Glu, 200 nM), insulin (Ins, 20 nM), or both. ∗∗, ∗∗∗ P < .01 and .001 vs corresponding basal; # P < .001 vs GFP + Glu; $ P < .05 vs Cre + Glu; & P < .01 vs GFP; 2-way ANOVA followed by Sidak’s post hoc test. ( B ) Cells were treated with vehicle (control) or the PKA inhibitors H89 (5 μM) and compound 3i (0.5 μM) in the absence or presence of glucagon (200 nM). ∗∗∗ P < .001 vs control + basal; & P < .001 vs control + Glu; 2-way ANOVA followed by Sidak’s post hoc test.

    Journal: Cellular and Molecular Gastroenterology and Hepatology

    Article Title: A Dual-compartment Scaffolding Role for Receptor for Activate C Kinase 1 in Hepatic Glucagon Signaling and Gluconeogenesis

    doi: 10.1016/j.jcmgh.2025.101666

    Figure Lengend Snippet: RACK1 deficiency impairs hepatic gluconeogenesis in vitro. Primary hepatocytes were isolated from RACK1 fl/fl mice injected with AAV8-TBG-GFP (GFP) or iCre (Cre) and subjected to glucose production assays. ( A ) Glucose output was measured under basal conditions or following stimulation with glucagon (Glu, 200 nM), insulin (Ins, 20 nM), or both. ∗∗, ∗∗∗ P < .01 and .001 vs corresponding basal; # P < .001 vs GFP + Glu; $ P < .05 vs Cre + Glu; & P < .01 vs GFP; 2-way ANOVA followed by Sidak’s post hoc test. ( B ) Cells were treated with vehicle (control) or the PKA inhibitors H89 (5 μM) and compound 3i (0.5 μM) in the absence or presence of glucagon (200 nM). ∗∗∗ P < .001 vs control + basal; & P < .001 vs control + Glu; 2-way ANOVA followed by Sidak’s post hoc test.

    Article Snippet: Acute deletion of RACK1 gene in the liver was achieved through the injection of AAV viruses (1 × 10 11 genome copies/mouse) encoding Cre recombinase under the TBG promoter (AAV-TBG-iCre; Vector Biolabs) into the retroorbital vein of RACK1 fl/fl transgenic mice.

    Techniques: In Vitro, Isolation, Injection, Control

    RACK1 deficiency attenuates hepatic PKA signaling. ( A–B ) RACK1 fl/fl mice injected with AAV8-TBG-iGFP (GFP) or AAV8-TBG-iCre (Cre) and fasted for 2 hours (basal) or treated with glucagon (100 μg/kg body weight; Glu) or insulin (1.5 U/kg body weight) for 15 minutes. Liver lysates were analyzed for cAMP levels ( A ) and by Western blotting ( B ). Quantified Western blot data are shown in the left panel. ∗∗∗ P < .001 vs corresponding basal. & P < .001 vs GFP + glucagon; 2-way ANOVA followed by Sidak’s post hoc test. ( C ) cAMP levels in primary hepatocytes stimulated with vehicle (basal) or glucagon (200 nM) for 10 minutes. ∗∗∗ P < .001 vs GFP + basal; 2-way ANOVA followed by Sidak’s post hoc test. ( D ) Western blot analysis of primary hepatocytes from GFP and Cre mice stimulated with vehicle (basal) or glucagon (200 nM) for the indicated times. Relative phosphorylation of pCREB S133 and phosphor-PKA substrates (pPKA sub) is expressed as fold change over GFP at 0 minutes, normalized to total protein ( left panel ). ∗, ∗∗∗ P < .05 and .001 vs Glu at 0 minutes, respectively; $ P < .001 vs Cre at 0 minutes; # P < .01 vs corresponding GFP; 2-way ANOVA followed by Sidak’s post hoc test. Arrows indicate pPKA sub unchanged or increased in RACK1-deficient cells. ( E ) Western blot analysis of primary hepatocytes from GFP and Cre mice stimulated with vehicle (basal), or insulin (20 nM) for the indicated times. Relative phosphorylation of pAKT S473 is expressed as fold change over GFP at 0 minutes, normalized to total protein (lower panel). ∗∗∗, # P < .001 vs corresponding Ins at 0 minutes; 2-way ANOVA followed by Sidak’s post hoc test. ( F ) qPCR analysis of PKA target genes G6PC and PCK1 in hepatocytes treated for 4 hours with vehicle, insulin (20 nM), glucagon (100 nM), glucagon + insulin, cAMP (20 μM), or cAMP + insulin. ∗∗∗ P < .001 vs corresponding basal; # P < .001 vs corresponding GFP; % P < .001 vs corresponding cAMP or glucagon; 2-way ANOVA followed by Sidak’s post hoc test. ( G ) qPCR analysis of the indicated genes in liver tissues from GFP and Cre mice following a 6-hour fast. ∗, ∗∗, ∗∗∗ P < .05, .01 and .001 vs GFP, respectively; 2-tailed Student’s t -test.

    Journal: Cellular and Molecular Gastroenterology and Hepatology

    Article Title: A Dual-compartment Scaffolding Role for Receptor for Activate C Kinase 1 in Hepatic Glucagon Signaling and Gluconeogenesis

    doi: 10.1016/j.jcmgh.2025.101666

    Figure Lengend Snippet: RACK1 deficiency attenuates hepatic PKA signaling. ( A–B ) RACK1 fl/fl mice injected with AAV8-TBG-iGFP (GFP) or AAV8-TBG-iCre (Cre) and fasted for 2 hours (basal) or treated with glucagon (100 μg/kg body weight; Glu) or insulin (1.5 U/kg body weight) for 15 minutes. Liver lysates were analyzed for cAMP levels ( A ) and by Western blotting ( B ). Quantified Western blot data are shown in the left panel. ∗∗∗ P < .001 vs corresponding basal. & P < .001 vs GFP + glucagon; 2-way ANOVA followed by Sidak’s post hoc test. ( C ) cAMP levels in primary hepatocytes stimulated with vehicle (basal) or glucagon (200 nM) for 10 minutes. ∗∗∗ P < .001 vs GFP + basal; 2-way ANOVA followed by Sidak’s post hoc test. ( D ) Western blot analysis of primary hepatocytes from GFP and Cre mice stimulated with vehicle (basal) or glucagon (200 nM) for the indicated times. Relative phosphorylation of pCREB S133 and phosphor-PKA substrates (pPKA sub) is expressed as fold change over GFP at 0 minutes, normalized to total protein ( left panel ). ∗, ∗∗∗ P < .05 and .001 vs Glu at 0 minutes, respectively; $ P < .001 vs Cre at 0 minutes; # P < .01 vs corresponding GFP; 2-way ANOVA followed by Sidak’s post hoc test. Arrows indicate pPKA sub unchanged or increased in RACK1-deficient cells. ( E ) Western blot analysis of primary hepatocytes from GFP and Cre mice stimulated with vehicle (basal), or insulin (20 nM) for the indicated times. Relative phosphorylation of pAKT S473 is expressed as fold change over GFP at 0 minutes, normalized to total protein (lower panel). ∗∗∗, # P < .001 vs corresponding Ins at 0 minutes; 2-way ANOVA followed by Sidak’s post hoc test. ( F ) qPCR analysis of PKA target genes G6PC and PCK1 in hepatocytes treated for 4 hours with vehicle, insulin (20 nM), glucagon (100 nM), glucagon + insulin, cAMP (20 μM), or cAMP + insulin. ∗∗∗ P < .001 vs corresponding basal; # P < .001 vs corresponding GFP; % P < .001 vs corresponding cAMP or glucagon; 2-way ANOVA followed by Sidak’s post hoc test. ( G ) qPCR analysis of the indicated genes in liver tissues from GFP and Cre mice following a 6-hour fast. ∗, ∗∗, ∗∗∗ P < .05, .01 and .001 vs GFP, respectively; 2-tailed Student’s t -test.

    Article Snippet: Acute deletion of RACK1 gene in the liver was achieved through the injection of AAV viruses (1 × 10 11 genome copies/mouse) encoding Cre recombinase under the TBG promoter (AAV-TBG-iCre; Vector Biolabs) into the retroorbital vein of RACK1 fl/fl transgenic mice.

    Techniques: Injection, Western Blot, Phospho-proteomics

    Glucagon regulates the dynamic interaction and compartmentation of RACK1 with components of the PKA signaling axis. ( A ) Coimmunoprecipitation of lysates from primary hepatocytes isolated from Alb-Cre/RACK1 fl/fl mice injected with pAd-GFP or pAd-Flag-RACK1 and treated with glucagon (200 nM) for the indicated times. Representative blot showing total proteins in input lysates and immunoprecipitated proteins in pellet fractions. ( B ) Quantification of RACK1-associated proteins from ( A ) after subtraction of GFP background, shown as fold enrichment relative to 0 minutes. ∗∗, ∗∗∗ P < .01 and .001 vs 0 minutes, respectively; n = 3; 1-way ANOVA followed by Dunnett’s post hoc test. ( C–D ) Western blot analysis of plasma membrane ( C ) and nuclear ( D ) fractions from primary hepatocytes isolated from RACK1 fl/fl mice injected with AAV8-TBG-iGFP (GFP) or AAV8-TBG-iCre (Cre) and stimulated with glucagon (200 nM) for the indicated time. Glucagon-induced changes in protein localization were quantified as fold change relative to 0 minutes in GFP cells and values are indicated below each blot. Quantitative data from multiple experiments are presented in left panels. ∗, ∗∗, ∗∗∗ P < .05, .01 and .001 vs GFP at 0 minutes, respectively; # P < .001 vs corresponding GFP; 2-way ANOVA followed by Sidak’s post hoc test.

    Journal: Cellular and Molecular Gastroenterology and Hepatology

    Article Title: A Dual-compartment Scaffolding Role for Receptor for Activate C Kinase 1 in Hepatic Glucagon Signaling and Gluconeogenesis

    doi: 10.1016/j.jcmgh.2025.101666

    Figure Lengend Snippet: Glucagon regulates the dynamic interaction and compartmentation of RACK1 with components of the PKA signaling axis. ( A ) Coimmunoprecipitation of lysates from primary hepatocytes isolated from Alb-Cre/RACK1 fl/fl mice injected with pAd-GFP or pAd-Flag-RACK1 and treated with glucagon (200 nM) for the indicated times. Representative blot showing total proteins in input lysates and immunoprecipitated proteins in pellet fractions. ( B ) Quantification of RACK1-associated proteins from ( A ) after subtraction of GFP background, shown as fold enrichment relative to 0 minutes. ∗∗, ∗∗∗ P < .01 and .001 vs 0 minutes, respectively; n = 3; 1-way ANOVA followed by Dunnett’s post hoc test. ( C–D ) Western blot analysis of plasma membrane ( C ) and nuclear ( D ) fractions from primary hepatocytes isolated from RACK1 fl/fl mice injected with AAV8-TBG-iGFP (GFP) or AAV8-TBG-iCre (Cre) and stimulated with glucagon (200 nM) for the indicated time. Glucagon-induced changes in protein localization were quantified as fold change relative to 0 minutes in GFP cells and values are indicated below each blot. Quantitative data from multiple experiments are presented in left panels. ∗, ∗∗, ∗∗∗ P < .05, .01 and .001 vs GFP at 0 minutes, respectively; # P < .001 vs corresponding GFP; 2-way ANOVA followed by Sidak’s post hoc test.

    Article Snippet: Acute deletion of RACK1 gene in the liver was achieved through the injection of AAV viruses (1 × 10 11 genome copies/mouse) encoding Cre recombinase under the TBG promoter (AAV-TBG-iCre; Vector Biolabs) into the retroorbital vein of RACK1 fl/fl transgenic mice.

    Techniques: Isolation, Injection, Immunoprecipitation, Western Blot, Clinical Proteomics, Membrane

    Rescue of glucose homeostasis defects induced by acute RACK1 deficiency via expression of constitutively active PKAcα W196R . ( A ) qPCR analysis of PKA target gene expression in livers of RACK1 fl/fl mice injected with AAV-TBG-GFP (RACK1 fl/fl /GFP), RACK1 fl/fl mice injected with AAV-TBG-Cre (RACK1 fl/fl /Cre), PKAca W196R mice injected with AAV-TBG-Cre (PKACA/Cre), or RACK1 fl/fl /PKAca W196R mice injected with AAV-TBG-Cre (RACK1 fl/fl /PKACA/Cre). ∗, ∗∗∗ P < .05 and .001 vs corresponding RACK1 fl/fl /GFP, respectively; 1-way ANOVA followed by Dunnett’s post hoc test. ( B ) Blood glucose levels in the indicated mice following an 18-hour fast. ∗, ∗∗ P < .05 and .01 vs RACK1 fl/fl /GFP, respectively; 1-way ANOVA followed by Dunnett’s post hoc test (n = 8). ( C–F ) Glucose tolerance test ( C ) with corresponding area under the curve (AUC) analysis ( D ), pyruvate tolerance test ( E ) with corresponding AUC analysis ( F ). Group differences over time were analyzed by 2-way repeated-measures ANOVA (time × genotype) with Sidak’s post hoc tests for point-by-point comparisons (n = 5–8 per group). AUCs were compared using 1-way ANOVA followed by Dunnett’s post hoc test. ∗, ∗∗, ∗∗∗ P < .05, .01, and .001 vs RACK1 fl/fl /GFP, respectively.

    Journal: Cellular and Molecular Gastroenterology and Hepatology

    Article Title: A Dual-compartment Scaffolding Role for Receptor for Activate C Kinase 1 in Hepatic Glucagon Signaling and Gluconeogenesis

    doi: 10.1016/j.jcmgh.2025.101666

    Figure Lengend Snippet: Rescue of glucose homeostasis defects induced by acute RACK1 deficiency via expression of constitutively active PKAcα W196R . ( A ) qPCR analysis of PKA target gene expression in livers of RACK1 fl/fl mice injected with AAV-TBG-GFP (RACK1 fl/fl /GFP), RACK1 fl/fl mice injected with AAV-TBG-Cre (RACK1 fl/fl /Cre), PKAca W196R mice injected with AAV-TBG-Cre (PKACA/Cre), or RACK1 fl/fl /PKAca W196R mice injected with AAV-TBG-Cre (RACK1 fl/fl /PKACA/Cre). ∗, ∗∗∗ P < .05 and .001 vs corresponding RACK1 fl/fl /GFP, respectively; 1-way ANOVA followed by Dunnett’s post hoc test. ( B ) Blood glucose levels in the indicated mice following an 18-hour fast. ∗, ∗∗ P < .05 and .01 vs RACK1 fl/fl /GFP, respectively; 1-way ANOVA followed by Dunnett’s post hoc test (n = 8). ( C–F ) Glucose tolerance test ( C ) with corresponding area under the curve (AUC) analysis ( D ), pyruvate tolerance test ( E ) with corresponding AUC analysis ( F ). Group differences over time were analyzed by 2-way repeated-measures ANOVA (time × genotype) with Sidak’s post hoc tests for point-by-point comparisons (n = 5–8 per group). AUCs were compared using 1-way ANOVA followed by Dunnett’s post hoc test. ∗, ∗∗, ∗∗∗ P < .05, .01, and .001 vs RACK1 fl/fl /GFP, respectively.

    Article Snippet: Acute deletion of RACK1 gene in the liver was achieved through the injection of AAV viruses (1 × 10 11 genome copies/mouse) encoding Cre recombinase under the TBG promoter (AAV-TBG-iCre; Vector Biolabs) into the retroorbital vein of RACK1 fl/fl transgenic mice.

    Techniques: Expressing, Targeted Gene Expression, Injection